Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease

Po Hui Wang, Yu Fan Liu, Hsiu Ting Tsai, Yi Torng Tee, Long Yau Lin, Yi Hsien Hsieh, Shun Fa Yang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Our purpose here was to detect the association among plasma osteopontin concentration, single nucleotide polymorphisms (SNPs) of osteopontin gene, and pelvic inflammatory disease (PID). The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were respectively used to measure the plasma osteopontin level and its gene polymorphisms. The level of plasma osteopontin was elevated in patients with PID as compared to that of healthy women and decreased significantly after treatment. Plasma osteopontin concentration was significantly correlated with white blood cell (WBC) and neutrophil counts and plasma C-reactive protein (CRP) level in patients with PID. No significant difference was found in the genotypes or alleles distribution of osteopontin SNPs, rs1126616 or rs9138, between patients with PID and normal controls. Plasma osteopontin concentration was not associated with osteopontin polymorphism. When the cutoff level of the plasma osteopontin concentration was set to be 58.53 ng/mL, the adjusted odds ratio of plasma osteopontin for PID risk was 3.87 (95% confident interval: 1.30-11.51). Plasma osteopontin level may act as a prediction marker for PID.

Original languageEnglish
Pages (from-to)1052-1058
Number of pages7
JournalReproductive Sciences
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 2010
Externally publishedYes

Fingerprint

Pelvic Inflammatory Disease
Osteopontin
Single Nucleotide Polymorphism
Leukocyte Count
Restriction Fragment Length Polymorphisms
C-Reactive Protein
Genes
Blood Proteins
Neutrophils
Enzyme-Linked Immunosorbent Assay
Alleles
Odds Ratio
Genotype

Keywords

  • osteopontin
  • pelvic inflammatory disease
  • single nucleotide polymorphism

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Wang, P. H., Liu, Y. F., Tsai, H. T., Tee, Y. T., Lin, L. Y., Hsieh, Y. H., & Yang, S. F. (2010). Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease. Reproductive Sciences, 17(11), 1052-1058. https://doi.org/10.1177/1933719110379270

Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease. / Wang, Po Hui; Liu, Yu Fan; Tsai, Hsiu Ting; Tee, Yi Torng; Lin, Long Yau; Hsieh, Yi Hsien; Yang, Shun Fa.

In: Reproductive Sciences, Vol. 17, No. 11, 11.2010, p. 1052-1058.

Research output: Contribution to journalArticle

Wang, PH, Liu, YF, Tsai, HT, Tee, YT, Lin, LY, Hsieh, YH & Yang, SF 2010, 'Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease', Reproductive Sciences, vol. 17, no. 11, pp. 1052-1058. https://doi.org/10.1177/1933719110379270
Wang, Po Hui ; Liu, Yu Fan ; Tsai, Hsiu Ting ; Tee, Yi Torng ; Lin, Long Yau ; Hsieh, Yi Hsien ; Yang, Shun Fa. / Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease. In: Reproductive Sciences. 2010 ; Vol. 17, No. 11. pp. 1052-1058.
@article{9349f2023c184e56a5267f3f9759aabc,
title = "Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease",
abstract = "Our purpose here was to detect the association among plasma osteopontin concentration, single nucleotide polymorphisms (SNPs) of osteopontin gene, and pelvic inflammatory disease (PID). The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were respectively used to measure the plasma osteopontin level and its gene polymorphisms. The level of plasma osteopontin was elevated in patients with PID as compared to that of healthy women and decreased significantly after treatment. Plasma osteopontin concentration was significantly correlated with white blood cell (WBC) and neutrophil counts and plasma C-reactive protein (CRP) level in patients with PID. No significant difference was found in the genotypes or alleles distribution of osteopontin SNPs, rs1126616 or rs9138, between patients with PID and normal controls. Plasma osteopontin concentration was not associated with osteopontin polymorphism. When the cutoff level of the plasma osteopontin concentration was set to be 58.53 ng/mL, the adjusted odds ratio of plasma osteopontin for PID risk was 3.87 (95{\%} confident interval: 1.30-11.51). Plasma osteopontin level may act as a prediction marker for PID.",
keywords = "osteopontin, pelvic inflammatory disease, single nucleotide polymorphism",
author = "Wang, {Po Hui} and Liu, {Yu Fan} and Tsai, {Hsiu Ting} and Tee, {Yi Torng} and Lin, {Long Yau} and Hsieh, {Yi Hsien} and Yang, {Shun Fa}",
year = "2010",
month = "11",
doi = "10.1177/1933719110379270",
language = "English",
volume = "17",
pages = "1052--1058",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease

AU - Wang, Po Hui

AU - Liu, Yu Fan

AU - Tsai, Hsiu Ting

AU - Tee, Yi Torng

AU - Lin, Long Yau

AU - Hsieh, Yi Hsien

AU - Yang, Shun Fa

PY - 2010/11

Y1 - 2010/11

N2 - Our purpose here was to detect the association among plasma osteopontin concentration, single nucleotide polymorphisms (SNPs) of osteopontin gene, and pelvic inflammatory disease (PID). The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were respectively used to measure the plasma osteopontin level and its gene polymorphisms. The level of plasma osteopontin was elevated in patients with PID as compared to that of healthy women and decreased significantly after treatment. Plasma osteopontin concentration was significantly correlated with white blood cell (WBC) and neutrophil counts and plasma C-reactive protein (CRP) level in patients with PID. No significant difference was found in the genotypes or alleles distribution of osteopontin SNPs, rs1126616 or rs9138, between patients with PID and normal controls. Plasma osteopontin concentration was not associated with osteopontin polymorphism. When the cutoff level of the plasma osteopontin concentration was set to be 58.53 ng/mL, the adjusted odds ratio of plasma osteopontin for PID risk was 3.87 (95% confident interval: 1.30-11.51). Plasma osteopontin level may act as a prediction marker for PID.

AB - Our purpose here was to detect the association among plasma osteopontin concentration, single nucleotide polymorphisms (SNPs) of osteopontin gene, and pelvic inflammatory disease (PID). The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were respectively used to measure the plasma osteopontin level and its gene polymorphisms. The level of plasma osteopontin was elevated in patients with PID as compared to that of healthy women and decreased significantly after treatment. Plasma osteopontin concentration was significantly correlated with white blood cell (WBC) and neutrophil counts and plasma C-reactive protein (CRP) level in patients with PID. No significant difference was found in the genotypes or alleles distribution of osteopontin SNPs, rs1126616 or rs9138, between patients with PID and normal controls. Plasma osteopontin concentration was not associated with osteopontin polymorphism. When the cutoff level of the plasma osteopontin concentration was set to be 58.53 ng/mL, the adjusted odds ratio of plasma osteopontin for PID risk was 3.87 (95% confident interval: 1.30-11.51). Plasma osteopontin level may act as a prediction marker for PID.

KW - osteopontin

KW - pelvic inflammatory disease

KW - single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=77958003048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958003048&partnerID=8YFLogxK

U2 - 10.1177/1933719110379270

DO - 10.1177/1933719110379270

M3 - Article

VL - 17

SP - 1052

EP - 1058

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 11

ER -